ReviewCurrent treatment options in oncology2022
High-Dose Somatostatin Analogs for the Treatment of Neuroendocrine Neoplasms: where are we Now?
Teresa Alonso-Gordoa et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it